Availability of clinical trials for Hawaii cancer patients. by Issell, B F
Cancer Research
Center Hotline
Availability of Clinical Trials for Hawaii
Cancer Patients
Brian F. IsseH MD
There are many hundreds of cancer centers throughout the countr\
hut onl about 50 of those in olved in patient care have achieved
National Cancer Institute designation based on research excellence.
The Cancer Research Center of Hawaii is one of them. Furthermore.
the Center is unique in that it does not operate its own treatment
facility. In order to minimize this deficiency on new treatment
opportunities for Hawaii cancer patients, the Center has worked
hard over many years to provide clinical trials through Hawaii’s
private community hospitals. private practitioners, and the Tripler
Army Medical Center.
The importance othaving patients and theirphv sicians participate
in clinical trials cannot be over emphasized All advances that have
been made in cancer care have been identified through participation
of patients in clinical trials. Clinical trials provide the scientific
evidence br treatment recommendations and guidelines.
A goal should be to enroll the majority of’ patients in clinical trials.
Since clinical trials results are the basis for treatment guidelines,
patients on clinical trials should be representative of those encoun
tered in everyday clinical practice. When only a minority of cancer
patients participate in clinical trials, there is reduced confidence that
treatment guidelines are appropriate forpatients commonly encoun
tered. This is especially pertinent to Hawaii’s multiethnic popula
tion whose treatment response ma be quite different to mainly
Caucasian patients attending tertiary referral centers on the main
land. the source of most evidence for current treatment recommen
dations.
The access of Hawaii’s cancer patients to national, peer-reviewed
clinical trials is an essential component of quality cancer care in our
state. Clinical trials provide potentially better treatments while
guaranteeing the best evidence-based care in a closely monitored
setting. Today. 40-50% of cancer patients cannot be cured by
currenttreatments. The National Institute of Health in areport to the
Senate Appropnation Committee stated: “For patients with life—
threatening disease for which standard thcrap is inadequate or
lacking altogether, participation in well—designed. closei inoni—
tored clinical trials represents best medical care for the patient. The
National Cancer Institute helie\ es that clinical trials are standard
therapy for cancer patients to whom a curative therapy cannot be
offered.
Helping healthcare providers maintain proficiency is a further
benefit of chnical trials participation. Physicians and other provid
ers who treat patients on clinical trials benefit from the continuing
education they derive in the process. Clinical trials protocols and
their introduction and promotion gis e provider.. information on up—
tn-date care and indicate the direction of future scientific ad ances.
Presently, the Center has more than It)>) clinical trials from
National Cancer Institute—supported clinical research groups in—
eluding many of the most promising ne treatments available at the
countr\ major cancer centers. This achievement has been made
possible through receiving since 199$. a highly competitive Minor
ity-Based. Community Clinical Oncology Program grant from the
National Cancer Institute. Only eight of these grants are awarded
throughout the U.S. Now, most Hawaii cancer patients do not have
to endure the additional burden of travel to the mainland for optimal
care. Also, we provide clinical trials that test ways to prevent the
most common cancers, such as of the breast and prostate, for
individuals who are at most risk for these diseases. Along with
clinical trials, we conduct seminars and lectures for the continuing
education of physicians and other health professionals in all aspects
of cancer care and prevention. We are especially proud that throuuh
the tireless efforts of Center staff and community professionals, we
have in recent years achie ed the participation of almr)st all Hawaii
clinical oncologists in our clinical trials and education activities.
National Cancer Institute— sponsored clinical trials are organized
in several national/international cooperative groups. Hawaii par
ticipates in the following: Southwest Oncology Group (SWOG),
Children’s Oncology Group (previously named Pediatric Oncology
Group. Gvnecologic Oncology Group (GOG), National Surgical
Adjuvant Breast and Bowel Project) NSABP) and Radiation Therap\
Oncology Group (RTOG). Community oncologists provide leader
ship for specific cooperative groups: .Ieffrev Berenberg. M.D. for
SWOG. Robert Wilkinson. M.D. for Children’s Oncolog Gi’oup.
Keith Terada. M.D. for GOG. Robert Oishi. M.D. for NSABP and
Paul DeMare. M.D. for
RTOG. Carolyn Gotay,
Ph.D., deputy director
of the Clinical Trials
Unit, provides leader
___________________________________
ship for all psvchoso
cial and behavioral
studies.
Contact the Clinical
Trials Unit at 586-2979
for an questions con
cerning clinical trials
foryourpatients. Clini
cal research associates
are available to help
evaluate the suitability
of your patient for an
acti\e clinical trial, to
assist oh counseling
involved in putting a
patient Ofl study, and to
facilitate study moni
toring and data collec
tion. Dorothy Coleman,
R.N.,M.S.ismanager
of the Clinical Trials
Unit. Brian lssell Ml)..
FACP is director of the
Unit.
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